SABS
SAB Biotherapeutics, Inc.- Sector
- Healthcare
- Industry
- Biotechnology
- Last price
- $3.48
- As of
Share the SABS intelligence card
See SABS live in the terminal
Track SABS's insider trades, 13F flows, options positioning, and cross asset confluence as they update, on one live board. Free account.
Open the live SABS terminal, freeActive signals for SABS
- mediumEARNINGS_BEAT
Q3-2025: Beat consensus by 70.9% - EPS $-0.15 vs $-0.5161 estimate
- mediumEARNINGS_MISS
Q2-2025: Missed consensus by 34.3% - EPS $-1.09 vs $-0.8119 estimate
- mediumEARNINGS_MISS
Q1-2026: Missed consensus by 50.3% - EPS $-0.35 vs $-0.2329 estimate
- mediumEARNINGS_MISS
Q4-2025: Missed consensus by 72.7% - EPS $-0.35 vs $-0.2027 estimate
Top institutional holders of SABS (13F)
| Fund | Market value | % portfolio | QoQ |
|---|---|---|---|
| MILLENNIUM MANAGEMENT LLC | $11.6M | 0.00% | +835.8% |
| MILLENNIUM MANAGEMENT LLC | $1.2M | 0.00% | , |
| TWO SIGMA INVESTMENTS, LP | $694K | 0.00% | , |
| RENAISSANCE TECHNOLOGIES LLC | $162K | 0.00% | , |
| CITADEL ADVISORS LLC | $66K | 0.00% | , |
Sourced from quarterly 13F filings with the U.S. Securities and Exchange Commission.
Recent SEC filings, SABS
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
Related tickers
Catch the next move on names like this
New 13F filings, insider trades, and cross asset signals like the ones above, in your inbox each morning or live on Telegram. Free, no account.
One email a day. Unsubscribe anytime. We never sell your data.
See more SABS signals as they fire
Kresmion publishes filings, 13F flows, on-chain whale activity, and cross-asset signals in real time. Open a live board scoped to SABSand get the insider, 13F, options, and confluence read in one view.